Final results of a phase II study of Taxotere (docetaxel, D), doxorubicin (Dx) and cyclophosphamide (CTX) (TAC) in thétreatment of metastatic breast cancer (MBC)
Title:
Final results of a phase II study of Taxotere (docetaxel, D), doxorubicin (Dx) and cyclophosphamide (CTX) (TAC) in thétreatment of metastatic breast cancer (MBC)
Author:
Nabholtz, J.-M. Mackey, J.R. Simylie, M. Paterson, A. Noel, D. Al-Twelgeri, T. Janowska-Wieczorek, A. Delome, F. Riva, A.